Onconova Therapeutics Story Overview

ONTX -- USA Stock  

USD 0.48  0.0227  4.52%

Macroaxis does not monitor all media channels or aggregates social signals for Onconova Therapeutics. But even though we do not provide professional-grade financial sentiment analysis on Onconova Therapeutics, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Onconova Therapeutics. Additionally take a look at Onconova Therapeutics Hype Analysis, Onconova Therapeutics Correlation and Onconova Therapeutics Performance.
Conversion by Michael Hoffman of 140449 shares of Onconova Therapeutics
Filed transaction by Onconova Therapeutics Inc director. Derivative codes conversion of derivative security

Onconova Therapeutics Inc insider trading alert for conversion of series c convertible preferred stock by Michael Hoffman, the corporate stakeholder, on March 8, 2018. This event was filed by Onconova Therapeutics Inc with SEC on 2013-08-01. Statement of changes in beneficial ownership - SEC Form 4

Story Momentum

This media report from MacroaxisInsider distributed on March 8, 2018 was a factor to the next trading day price appreciation.The trading delta at closing time against the next closing price was 0.94% . The trading delta at closing time when the story was published against the current closing price is 51.89% .

Similar stores for Onconova Therapeutics

3 days ago at http://simplywall.st 
Onconova Therapeutics Inc When Will It Breakeven
news
Simply Wall StShort Term Look Onconova Therapeutics, Inc. Stocks GalleryWhich is more compelling pick right now Onconova Therapeutics, Inc. , La-Z-Boy Incorporated StockNewsGazetteFull coverage
few days ago at http://alphabetastock.com 
Do Investors Feel Confident About Stocks Future Direction Onconova Therapeutics Inc
news
Alpha Beta StockFull coverage
over a week ago at http://alphabetastock.com 
Trending Hot Stocks Analysis Onconova Therapeutics Inc
news
Alpha Beta StockFull coverage
over a week ago at http://www.stocknewsgazette.com 
Are These Stocks A Sure Bet Onconova Therapeutics, Inc. , SenesTech, Inc.
news
StockNewsGazetteFull coverage
over two weeks ago at http://www.nasdaqfortune.com 
Onconova Therapeutics, Inc. receives consensus rating of 2.00
nasdaq News
Nasdaq Fortune Full coverage
over two weeks ago at http://cointradejournal.com 
Onconova Therapeutics, Inc. 20-Day Moving Average Signal a Buy
news
Coin JournalFull coverage
over three weeks ago at http://alphabetastock.com 
Guide to Day Traders Onconova Therapeutics Inc
news
Alpha Beta StockFull coverage
over a month ago at http://www.stocksnewspoint.com 
Onconova Therapeutics, Inc. , Sally Beauty Holdings, Inc. , Sphere 3D Corp. NASDAQ ...
news
Stocks News Point Full coverage
over a month ago at http://www.stocksnewspoint.com 
Onconova Therapeutics, Inc. , InspireMD, Inc. Traders Round Up
news
Stocks News Point Full coverage
over a month ago at http://www.journalfinance.net 
Bustling Stocks Onconova Therapeutics, Inc. , Sea Limited , Charles Colvard, Ltd ...
news
Market Breaking Point Full coverage
over two months ago at http://www.mmahotstuff.com 
EPS for Onconova Therapeutics, Inc. Expected At -0.32 Banque Pictet Cie Sa Cut By 6.98 Million Its US ...
news
MoneyMakingArticlesFull coverage

Did you try this?

Run Portfolio Center Now
   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Portfolio Center

Short Ratio

Short Ratio Comparative Analysis
  Short Ratio 
      Onconova Therapeutics Comparables 
Onconova Therapeutics is currently under evaluation in short ratio category among related companies. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

Peers

Onconova Therapeutics Related Equities
DOVA  5.92 %   
0%
84.0%
DNLI  5.53 %   
0%
79.0%
DRNA  4.36 %   
0%
62.0%
NK  3.53 %   
0%
50.0%
VCEL  0.46 %   
0%
6.0%
DMTX  0.00 %   
0%
0%
DRRX  2.01 %   
28.0%
0%
VBIV  5.02 %   
71.0%
0%
VBLT  5.66 %   
81.0%
0%
DMPI  6.98 %   
100.0%
0%
Additionally take a look at Onconova Therapeutics Hype Analysis, Onconova Therapeutics Correlation and Onconova Therapeutics Performance. Please also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.